Thiosalicylic Acid
CAS 147-93-3
Thiosalicylic Acid (CAS 147-93-3) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | IC50 | 19994.735555555555 nM | 8 | - |
| - | Potency | 40759.433333333334 nM | 6 | - |
| - | AC50 | 17782.8 nM | 1 | - |
| - | EC50 | 16900 nM | 1 | - |
| - | Ki | 9200 nM | 1 | - |
| Histone deacetylase 8 Enzyme |
EC50 | 4.77 | - | Homo sapiens |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Thiosalicylic Acid used for in pharmaceutical contexts?
Thiosalicylic Acid (CAS 147-93-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Thiosalicylic Acid?
No adverse-event association or SIDER side-effect rows are rendered for Thiosalicylic Acid in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Thiosalicylic Acid also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Thiosalicylic Acid with EU status "permitted".
What clinical phase is Thiosalicylic Acid in?
No phase 1-4 clinical development badge is rendered for Thiosalicylic Acid because the matched compound identifier rows do not contain a max-phase value.
What bioactivity targets are documented for Thiosalicylic Acid?
Thiosalicylic Acid has 5 bioactivity rows in this page query. Rendered target entries include Histone deacetylase 8.